← back to search

Louise Scharf

California Institute of Technology · US
Area of research
Immunology · Virology
Research interest
Research interests include HIV Research and Treatment, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research, and T-cell and B-cell Immunology.
h-index
18
citations
3,432
works
34
NIH funding
primary concept
email

Recent publications

Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller
Science Translational Medicine 2017cited by 176position: middledoi
Structural basis for germline antibody recognition of HIV-1 immunogens
eLife 2016cited by 77position: firstdoi
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
Cell 2015cited by 278position: middledoi
Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env
Cell 2015cited by 147position: firstdoi
Antibody engineering for increased potency, breadth and half-life
Current Opinion in HIV and AIDS 2015cited by 56position: middledoi
A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo
PLoS Pathogens 2015cited by 55position: middledoi
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
Cell 2014cited by 332position: middledoi
Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
Cell Reports 2014cited by 214position: firstdoi
Antibodies in HIV-1 Vaccine Development and Therapy
Science 2013cited by 472position: middledoi
Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells
Immunity 2013cited by 245position: middledoi
Computational analysis of anti–HIV-1 antibody neutralization panel data to identify potential functional epitope residues
Proceedings of the National Academy of Sciences 2013cited by 151position: middledoi
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody
Proceedings of the National Academy of Sciences 2013cited by 74position: firstdoi
Highly Stereocontrolled Total Synthesis of β-<scp>d</scp>-Mannosyl Phosphomycoketide: A Natural Product from <i>Mycobacterium tuberculosis</i>
The Journal of Organic Chemistry 2013cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Pamela J. Björkman · California Institute of Technology10 papers (2013–2017)Michel C. Nussenzweig · Rockefeller University9 papers (2013–2017)Anthony P. West · California Institute of Technology7 papers (2013–2017)Johannes F. Scheid · Broad Institute6 papers (2013–2016)Michael S. Seaman · Harvard University4 papers (2014–2017)Florian Klein · Chirurgische Universitätsklinik Heidelberg4 papers (2013–2015)Stuart A. Sievers · Gilead Sciences (Australia)4 papers (2015–2017)Han Gao · California Institute of Technology4 papers (2013–2016)Anna Gazumyan · Rockefeller University3 papers (2015–2017)Rogier W. Sanders · Scripps Research Institute3 papers (2015–2017)Natalia T. Freund · Tel Aviv University3 papers (2015–2017)Joshua A. Horwitz · Rockefeller University3 papers (2013–2017)Pia Dosenovic · Rockefeller University2 papers (2013–2015)Haoqing Wang · Palo Alto University2 papers (2015–2017)Leonidas Stamatatos · Fred Hutch Cancer Center2 papers (2015–2016)Bruce D. Walker · Active Technologies (Italy)2 papers (2015–2017)Marit J. van Gils · Amsterdam University Medical Centers2 papers (2015–2017)Matthew D. Gray · National Institute of Allergy and Infectious Diseases2 papers (2015–2016)John P. Moore · Cornell University2 papers (2015–2015)Andrew T. McGuire · Fred Hutch Cancer Center2 papers (2015–2016)